HEADER IMMUNE SYSTEM 28-SEP-06 2J6E TITLE CRYSTAL STRUCTURE OF AN AUTOIMMUNE COMPLEX BETWEEN A HUMAN IGM TITLE 2 RHEUMATOID FACTOR AND IGG1 FC REVEALS A NOVEL FC EPITOPE AND EVIDENCE TITLE 3 FOR AFFINITY MATURATION CAVEAT 2J6E NAG C 5 HAS WRONG CHIRALITY AT ATOM C1 COMPND MOL_ID: 1; COMPND 2 MOLECULE: IG GAMMA-1 CHAIN C REGION; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: FC DOMAIN, RESIDUES 99-330; COMPND 5 SYNONYM: IGG1; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: IGM; COMPND 9 CHAIN: H, I; COMPND 10 SYNONYM: FAB HEAVY CHAIN; COMPND 11 ENGINEERED: YES; COMPND 12 MOL_ID: 3; COMPND 13 MOLECULE: IGM; COMPND 14 CHAIN: L, M; COMPND 15 SYNONYM: FAB LIGHT CHAIN; COMPND 16 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: CRICETULUS GRISEUS; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 10029; SOURCE 7 EXPRESSION_SYSTEM_CELL_LINE: CHO; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 10 ORGANISM_COMMON: HUMAN; SOURCE 11 ORGANISM_TAXID: 9606; SOURCE 12 CELL: B-LYMPHOCYTE; SOURCE 13 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 14 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 15 OTHER_DETAILS: CD5POSITIVE B CELLS; SOURCE 16 MOL_ID: 3; SOURCE 17 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 18 ORGANISM_COMMON: HUMAN; SOURCE 19 ORGANISM_TAXID: 9606; SOURCE 20 CELL: B-LYMPHOCYTE; SOURCE 21 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 22 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 23 OTHER_DETAILS: CD5POSITIVE B CELLS KEYWDS AUTOIMMUNE COMPLEX HUMAN IGM RHEUMATOID FACTOR IGG1-FC, KEYWDS 2 IMMUNOGLOBULIN C REGION, MEMBRANE, GLYCOPROTEIN, TRANSMEMBRANE, KEYWDS 3 HYPOTHETICAL PROTEIN, IMMUNE SYSTEM, IMMUNOGLOBULIN DOMAIN EXPDTA X-RAY DIFFRACTION AUTHOR S.DUQUERROY,E.A.STURA,S.BRESSANELLI,H.BROWNE,D.BEALE,M.HAMON, AUTHOR 2 P.CASALI,M.C.VANEY,F.A.REY,B.J.SUTTON,M.J.TAUSSIG REVDAT 10 13-DEC-23 2J6E 1 REMARK REVDAT 9 11-MAY-22 2J6E 1 CAVEAT COMPND HET HETNAM REVDAT 9 2 1 HETSYN FORMUL LINK ATOM REVDAT 8 04-MAY-22 2J6E 1 HETSYN LINK ATOM REVDAT 7 29-JUL-20 2J6E 1 COMPND REMARK HETNAM LINK REVDAT 7 2 1 SITE ATOM REVDAT 6 14-AUG-19 2J6E 1 AUTHOR JRNL REMARK REVDAT 5 03-APR-19 2J6E 1 SOURCE LINK REVDAT 4 24-FEB-09 2J6E 1 VERSN REVDAT 3 29-JUL-08 2J6E 1 VERSN REVDAT 2 08-MAY-07 2J6E 1 JRNL REVDAT 1 10-APR-07 2J6E 0 JRNL AUTH S.DUQUERROY,E.A.STURA,S.BRESSANELLI,S.M.FABIANE,M.C.VANEY, JRNL AUTH 2 D.BEALE,M.HAMON,P.CASALI,F.A.REY,B.J.SUTTON,M.J.TAUSSIG JRNL TITL CRYSTAL STRUCTURE OF A HUMAN AUTOIMMUNE COMPLEX BETWEEN IGM JRNL TITL 2 RHEUMATOID FACTOR RF61 AND IGG1 FC REVEALS A NOVEL EPITOPE JRNL TITL 3 AND EVIDENCE FOR AFFINITY MATURATION. JRNL REF J.MOL.BIOL. V. 368 1321 2007 JRNL REFN ISSN 0022-2836 JRNL PMID 17395205 JRNL DOI 10.1016/J.JMB.2007.02.085 REMARK 2 REMARK 2 RESOLUTION. 3.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 25.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 10000.000 REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 95.3 REMARK 3 NUMBER OF REFLECTIONS : 35995 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.223 REMARK 3 FREE R VALUE : 0.288 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 6.800 REMARK 3 FREE R VALUE TEST SET COUNT : 2563 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 9819 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 292 REMARK 3 SOLVENT ATOMS : 84 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -37.92800 REMARK 3 B22 (A**2) : 15.85000 REMARK 3 B33 (A**2) : 22.07800 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 6.47200 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.43 REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : 25.0 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 BOND ANGLES (DEGREES) : 1.369 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 25.60 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.950 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : 0.25 REMARK 3 BSOL : 26.64 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : CARBOHYDRATE.PARAM REMARK 3 PARAMETER FILE 3 : ION.PARAM REMARK 3 PARAMETER FILE 4 : WATER.PARAM REMARK 3 PARAMETER FILE 5 : CACO.PAR REMARK 3 PARAMETER FILE 6 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 TOPOLOGY FILE 2 : NULL REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 TOPOLOGY FILE 6 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2J6E COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 28-SEP-06. REMARK 100 THE DEPOSITION ID IS D_1290030026. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 6.50 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID14-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.934 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 36545 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.000 REMARK 200 RESOLUTION RANGE LOW (A) : 25.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.9 REMARK 200 DATA REDUNDANCY : 3.600 REMARK 200 R MERGE (I) : 0.08000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 14.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.11 REMARK 200 COMPLETENESS FOR SHELL (%) : 93.8 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.42000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.200 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRIES 1DN2, 2FB4 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 52.10 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.28 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 10% MPEG 5000, 3 MM ZINC ACETATE, 3 MM REMARK 280 CDCL2, 100 MM SODIUM CACODYLATE PH 6.5, PH 6.50, VAPOR DIFFUSION, REMARK 280 SITTING DROP REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 120.99000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 37.80500 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 120.99000 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 37.80500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: HEXAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: HEXAMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 TOTAL BURIED SURFACE AREA: 14400 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 70770 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -78.3 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, H, I, L, M, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLU A 216 REMARK 465 PRO A 217 REMARK 465 LYS A 218 REMARK 465 SER A 219 REMARK 465 CYS A 220 REMARK 465 ASP A 221 REMARK 465 LYS A 222 REMARK 465 THR A 223 REMARK 465 HIS A 224 REMARK 465 THR A 225 REMARK 465 CYS A 226 REMARK 465 PRO A 227 REMARK 465 PRO A 228 REMARK 465 CYS A 229 REMARK 465 PRO A 230 REMARK 465 ALA A 231 REMARK 465 PRO A 232 REMARK 465 GLU A 233 REMARK 465 LEU A 234 REMARK 465 LEU A 235 REMARK 465 GLY A 446 REMARK 465 LYS A 447 REMARK 465 GLU B 216 REMARK 465 PRO B 217 REMARK 465 LYS B 218 REMARK 465 SER B 219 REMARK 465 CYS B 220 REMARK 465 ASP B 221 REMARK 465 LYS B 222 REMARK 465 THR B 223 REMARK 465 HIS B 224 REMARK 465 THR B 225 REMARK 465 CYS B 226 REMARK 465 PRO B 227 REMARK 465 PRO B 228 REMARK 465 CYS B 229 REMARK 465 PRO B 230 REMARK 465 ALA B 231 REMARK 465 PRO B 232 REMARK 465 GLU B 233 REMARK 465 LEU B 234 REMARK 465 LEU B 235 REMARK 465 GLY B 236 REMARK 465 GLY B 237 REMARK 465 LYS B 447 REMARK 465 LEU H -10 REMARK 465 LEU H -9 REMARK 465 LEU H -8 REMARK 465 VAL H -7 REMARK 465 ALA H -6 REMARK 465 ALA H -5 REMARK 465 PRO H -4 REMARK 465 ARG H -3 REMARK 465 TRP H -2 REMARK 465 LEU H -1 REMARK 465 SER H 0 REMARK 465 SER H 130 REMARK 465 CYS H 131 REMARK 465 ASP H 132 REMARK 465 THR H 133 REMARK 465 LEU I -10 REMARK 465 LEU I -9 REMARK 465 LEU I -8 REMARK 465 VAL I -7 REMARK 465 ALA I -6 REMARK 465 ALA I -5 REMARK 465 PRO I -4 REMARK 465 ARG I -3 REMARK 465 TRP I -2 REMARK 465 LEU I -1 REMARK 465 SER I 0 REMARK 465 MET L -18 REMARK 465 ALA L -17 REMARK 465 GLY L -16 REMARK 465 PHE L -15 REMARK 465 PRO L -14 REMARK 465 LEU L -13 REMARK 465 LEU L -12 REMARK 465 LEU L -11 REMARK 465 THR L -10 REMARK 465 LEU L -9 REMARK 465 LEU L -8 REMARK 465 THR L -7 REMARK 465 HIS L -6 REMARK 465 CYS L -5 REMARK 465 ALA L -4 REMARK 465 GLY L -3 REMARK 465 SER L -2 REMARK 465 TRP L -1 REMARK 465 ALA L 0 REMARK 465 CYS L 211 REMARK 465 MET M -18 REMARK 465 ALA M -17 REMARK 465 GLY M -16 REMARK 465 PHE M -15 REMARK 465 PRO M -14 REMARK 465 LEU M -13 REMARK 465 LEU M -12 REMARK 465 LEU M -11 REMARK 465 THR M -10 REMARK 465 LEU M -9 REMARK 465 LEU M -8 REMARK 465 THR M -7 REMARK 465 HIS M -6 REMARK 465 CYS M -5 REMARK 465 ALA M -4 REMARK 465 GLY M -3 REMARK 465 SER M -2 REMARK 465 TRP M -1 REMARK 465 ALA M 0 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 PRO A 445 CA C O CB CG CD REMARK 470 PRO B 238 CG CD REMARK 470 GLY B 446 CA C O REMARK 470 GLU L 210 CA C O CB CG CD OE1 REMARK 470 GLU L 210 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 N GLY H 96 O GLY H 100D 2.16 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 CYS H 92 CA - CB - SG ANGL. DEV. = 6.7 DEGREES REMARK 500 CYS I 92 CA - CB - SG ANGL. DEV. = 8.9 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ILE A 253 -31.81 -37.90 REMARK 500 ASP A 265 40.64 72.06 REMARK 500 ASN A 297 38.15 -95.37 REMARK 500 SER A 337 158.63 167.04 REMARK 500 LYS A 338 152.05 -47.79 REMARK 500 PRO A 352 170.07 -57.93 REMARK 500 ASN A 384 47.54 25.68 REMARK 500 PRO A 387 -164.23 -71.72 REMARK 500 LYS A 414 -39.71 -37.79 REMARK 500 GLU B 258 143.95 -171.60 REMARK 500 ASP B 265 77.64 63.58 REMARK 500 SER B 267 170.49 -53.14 REMARK 500 GLU B 269 -78.50 -54.68 REMARK 500 GLU B 272 120.06 -37.33 REMARK 500 VAL B 282 155.24 -46.23 REMARK 500 ASN B 286 88.69 177.70 REMARK 500 ALA B 287 81.95 -153.33 REMARK 500 LYS B 288 147.85 -36.95 REMARK 500 GLU B 293 108.38 -57.20 REMARK 500 ASN B 297 57.16 -156.09 REMARK 500 HIS B 310 -77.09 -37.14 REMARK 500 ASN B 315 70.14 -103.52 REMARK 500 ALA B 327 26.35 -67.40 REMARK 500 ALA B 330 73.98 -110.01 REMARK 500 PRO B 331 100.31 -29.92 REMARK 500 ILE B 332 138.45 -38.90 REMARK 500 GLN B 342 108.06 -48.31 REMARK 500 TYR B 436 130.98 -170.99 REMARK 500 SER B 442 148.74 -175.84 REMARK 500 PRO B 445 103.56 -56.71 REMARK 500 PRO H 14 151.16 -37.92 REMARK 500 SER H 15 -17.42 64.61 REMARK 500 GLU H 16 -165.14 -67.90 REMARK 500 PRO H 41 -56.52 -24.52 REMARK 500 LYS H 43 -163.45 -57.13 REMARK 500 ASN H 56 121.23 -37.84 REMARK 500 LEU H 63 27.83 -151.47 REMARK 500 THR H 83 -158.81 -124.02 REMARK 500 ASP H 86 28.66 -57.38 REMARK 500 ALA H 88 -168.33 -167.18 REMARK 500 SER H 113 -8.44 -147.06 REMARK 500 SER H 115 146.63 85.80 REMARK 500 ALA H 116 178.40 -56.00 REMARK 500 SER H 117 134.89 177.30 REMARK 500 SER H 135 68.17 74.40 REMARK 500 LEU H 141 174.59 -50.23 REMARK 500 ALA H 142 116.54 -178.22 REMARK 500 GLN H 143 -160.14 -115.51 REMARK 500 ASP H 144 -58.58 80.94 REMARK 500 LEU H 146 -64.29 -102.91 REMARK 500 REMARK 500 THIS ENTRY HAS 185 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CD A 501 CD REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS A 268 NE2 REMARK 620 2 GLU A 294 OE1 116.2 REMARK 620 3 GLU A 294 OE2 79.0 50.4 REMARK 620 4 HIS A 310 NE2 113.6 108.4 96.0 REMARK 620 5 HIS A 435 NE2 93.5 111.5 150.4 113.1 REMARK 620 N 1 2 3 4 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A 502 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 GLU A 272 OE1 REMARK 620 2 GLU A 272 OE2 66.3 REMARK 620 3 GLU A 345 OE1 118.1 174.0 REMARK 620 4 GLU A 345 OE2 69.7 129.8 56.0 REMARK 620 5 HIS A 433 NE2 103.3 83.7 91.1 129.7 REMARK 620 6 CAC A 503 O1 101.8 80.3 102.1 86.3 141.6 REMARK 620 N 1 2 3 4 5 REMARK 700 REMARK 700 SHEET REMARK 700 THE SHEET STRUCTURE OF THIS MOLECULE IS BIFURCATED. IN REMARK 700 ORDER TO REPRESENT THIS FEATURE IN THE SHEET RECORDS BELOW, REMARK 700 TWO SHEETS ARE DEFINED. REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1AJ7 RELATED DB: PDB REMARK 900 IMMUNOGLOBULIN 48G7 GERMLINE FAB ANTIBODY COMPLEXED WITH HAPTEN 5- REMARK 900 (PARA-NITROPHENYL PHOSPHONATE)-PENTANOIC ACID. AFFINITY MATURATION REMARK 900 OF AN ESTEROLYTIC ANTIBODY REMARK 900 RELATED ID: 1AQK RELATED DB: PDB REMARK 900 THREE-DIMENSIONAL STRUCTURE OF A HUMAN FAB WITH HIGH AFFINITY FOR REMARK 900 TETANUS TOXOID REMARK 900 RELATED ID: 1D5B RELATED DB: PDB REMARK 900 UNLIGANDED MATURE OXY-COPE CATALYTIC ANTIBODY REMARK 900 RELATED ID: 1D5I RELATED DB: PDB REMARK 900 UNLIGANDED GERMLINE PRECURSOR OF AN OXY-COPE CATALYTIC ANTIBODY REMARK 900 RELATED ID: 1D6V RELATED DB: PDB REMARK 900 CONFORMATION EFFECTS IN BIOLOGICAL CATALYSIS INTRODUCED BY OXY-COPE REMARK 900 ANTIBODY MATURATION REMARK 900 RELATED ID: 1DN2 RELATED DB: PDB REMARK 900 FC FRAGMENT OF HUMAN IGG1 IN COMPLEX WITH AN ENGINEERED 13 RESIDUE REMARK 900 PEPTIDE DCAWHLGELVWCT-NH2 REMARK 900 RELATED ID: 1E4K RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF SOLUBLE HUMAN IGG1 FC FRAGMENT-FC-GAMMA REMARK 900 RECEPTOR III COMPLEX REMARK 900 RELATED ID: 1FC1 RELATED DB: PDB REMARK 900 FC FRAGMENT (IGG1 CLASS) REMARK 900 RELATED ID: 1FC2 RELATED DB: PDB REMARK 900 RELATED ID: 1FCC RELATED DB: PDB REMARK 900 RELATED ID: 1H3T RELATED DB: PDB REMARK 900 STRUCTURAL ANALYSIS OF HUMAN IGG-FC GLYCOFORMS REVEALS A REMARK 900 CORRELATION BETWEEN GLYCOSYLATION AND STRUCTURAL INTEGRITY REMARK 900 RELATED ID: 1H3U RELATED DB: PDB REMARK 900 STRUCTURAL ANALYSIS OF HUMAN IGG-FC GLYCOFORMS REVEALS A REMARK 900 CORRELATION BETWEEN GLYCOSYLATION AND STRUCTURAL INTEGRITY REMARK 900 RELATED ID: 1H3V RELATED DB: PDB REMARK 900 STRUCTURAL ANALYSIS OF HUMAN IGG-FC GLYCOFORMS REVEALS A REMARK 900 CORRELATION BETWEEN GLYCOSYLATION AND STRUCTURAL INTEGRITY REMARK 900 RELATED ID: 1H3W RELATED DB: PDB REMARK 900 STRUCTURAL ANALYSIS OF HUMAN IGG-FC GLYCOFORMS REVEALS A REMARK 900 CORRELATION BETWEEN GLYCOSYLATION AND STRUCTURAL INTEGRITY REMARK 900 RELATED ID: 1H3Y RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF A HUMAN IGG1 FC- FRAGMENT,HIGH SALTCONDITION REMARK 900 RELATED ID: 1HZH RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE INTACT HUMAN IGG B12 WITH BROADAND POTENT REMARK 900 ACTIVITY AGAINST PRIMARY HIV-1 ISOLATES: ATEMPLATE FOR HIV VACCINE REMARK 900 DESIGN REMARK 900 RELATED ID: 1I7Z RELATED DB: PDB REMARK 900 ANTIBODY GNC92H2 BOUND TO LIGAND REMARK 900 RELATED ID: 1IIS RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF A HUMAN FCG RECEPTOR IN COMPLEX WITHAN FC REMARK 900 FRAGMENT OF IGG1 ( ORTHORHOMBIC) REMARK 900 RELATED ID: 1IIX RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF A HUMAN FCG RECEPTOR IN COMPLEX WITHAN FC REMARK 900 FRAGMENT OF IGG1 ( HEXAGONAL) REMARK 900 RELATED ID: 1L6X RELATED DB: PDB REMARK 900 FC FRAGMENT OF RITUXIMAB BOUND TO A MINIMIZED VERSION OFTHE B- REMARK 900 DOMAIN FROM PROTEIN A CALLED Z34C REMARK 900 RELATED ID: 1N7M RELATED DB: PDB REMARK 900 GERMLINE 7G12 WITH N-METHYLMESOPORPHYRIN REMARK 900 RELATED ID: 1OQX RELATED DB: PDB REMARK 900 G-2 GLYCOVARIANT OF HUMAN IGG FC BOUND TO MINIMIZED VERSIONOF REMARK 900 PROTEIN A CALLED Z34C REMARK 900 RELATED ID: 1T83 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF A HUMAN TYPE III FC GAMMA RECEPTOR INCOMPLEX REMARK 900 WITH AN FC FRAGMENT OF IGG1 (ORTHORHOMBIC) REMARK 900 RELATED ID: 2IWG RELATED DB: PDB REMARK 900 T.B.C REMARK 900 RELATED ID: 2RCS RELATED DB: PDB REMARK 900 IMMUNOGLOBULIN 48G7 GERMLINE FAB - AFFINITY MATURATION OF AN REMARK 900 ESTEROLYTIC ANTIBODY DBREF 2J6E A 216 447 UNP P01857 IGHG1_HUMAN 99 330 DBREF 2J6E B 216 447 UNP P01857 IGHG1_HUMAN 99 330 DBREF 2J6E H -10 214 PDB 2J6E 2J6E -10 214 DBREF 2J6E I -10 214 PDB 2J6E 2J6E -10 214 DBREF 2J6E L -18 211 PDB 2J6E 2J6E -18 211 DBREF 2J6E M -18 211 PDB 2J6E 2J6E -18 211 SEQADV 2J6E GLU A 270 UNP P01857 ASP 153 CONFLICT SEQADV 2J6E GLU B 270 UNP P01857 ASP 153 CONFLICT SEQRES 1 A 232 GLU PRO LYS SER CYS ASP LYS THR HIS THR CYS PRO PRO SEQRES 2 A 232 CYS PRO ALA PRO GLU LEU LEU GLY GLY PRO SER VAL PHE SEQRES 3 A 232 LEU PHE PRO PRO LYS PRO LYS ASP THR LEU MET ILE SER SEQRES 4 A 232 ARG THR PRO GLU VAL THR CYS VAL VAL VAL ASP VAL SER SEQRES 5 A 232 HIS GLU GLU PRO GLU VAL LYS PHE ASN TRP TYR VAL ASP SEQRES 6 A 232 GLY VAL GLU VAL HIS ASN ALA LYS THR LYS PRO ARG GLU SEQRES 7 A 232 GLU GLN TYR ASN SER THR TYR ARG VAL VAL SER VAL LEU SEQRES 8 A 232 THR VAL LEU HIS GLN ASP TRP LEU ASN GLY LYS GLU TYR SEQRES 9 A 232 LYS CYS LYS VAL SER ASN LYS ALA LEU PRO ALA PRO ILE SEQRES 10 A 232 GLU LYS THR ILE SER LYS ALA LYS GLY GLN PRO ARG GLU SEQRES 11 A 232 PRO GLN VAL TYR THR LEU PRO PRO SER ARG ASP GLU LEU SEQRES 12 A 232 THR LYS ASN GLN VAL SER LEU THR CYS LEU VAL LYS GLY SEQRES 13 A 232 PHE TYR PRO SER ASP ILE ALA VAL GLU TRP GLU SER ASN SEQRES 14 A 232 GLY GLN PRO GLU ASN ASN TYR LYS THR THR PRO PRO VAL SEQRES 15 A 232 LEU ASP SER ASP GLY SER PHE PHE LEU TYR SER LYS LEU SEQRES 16 A 232 THR VAL ASP LYS SER ARG TRP GLN GLN GLY ASN VAL PHE SEQRES 17 A 232 SER CYS SER VAL MET HIS GLU ALA LEU HIS ASN HIS TYR SEQRES 18 A 232 THR GLN LYS SER LEU SER LEU SER PRO GLY LYS SEQRES 1 B 232 GLU PRO LYS SER CYS ASP LYS THR HIS THR CYS PRO PRO SEQRES 2 B 232 CYS PRO ALA PRO GLU LEU LEU GLY GLY PRO SER VAL PHE SEQRES 3 B 232 LEU PHE PRO PRO LYS PRO LYS ASP THR LEU MET ILE SER SEQRES 4 B 232 ARG THR PRO GLU VAL THR CYS VAL VAL VAL ASP VAL SER SEQRES 5 B 232 HIS GLU GLU PRO GLU VAL LYS PHE ASN TRP TYR VAL ASP SEQRES 6 B 232 GLY VAL GLU VAL HIS ASN ALA LYS THR LYS PRO ARG GLU SEQRES 7 B 232 GLU GLN TYR ASN SER THR TYR ARG VAL VAL SER VAL LEU SEQRES 8 B 232 THR VAL LEU HIS GLN ASP TRP LEU ASN GLY LYS GLU TYR SEQRES 9 B 232 LYS CYS LYS VAL SER ASN LYS ALA LEU PRO ALA PRO ILE SEQRES 10 B 232 GLU LYS THR ILE SER LYS ALA LYS GLY GLN PRO ARG GLU SEQRES 11 B 232 PRO GLN VAL TYR THR LEU PRO PRO SER ARG ASP GLU LEU SEQRES 12 B 232 THR LYS ASN GLN VAL SER LEU THR CYS LEU VAL LYS GLY SEQRES 13 B 232 PHE TYR PRO SER ASP ILE ALA VAL GLU TRP GLU SER ASN SEQRES 14 B 232 GLY GLN PRO GLU ASN ASN TYR LYS THR THR PRO PRO VAL SEQRES 15 B 232 LEU ASP SER ASP GLY SER PHE PHE LEU TYR SER LYS LEU SEQRES 16 B 232 THR VAL ASP LYS SER ARG TRP GLN GLN GLY ASN VAL PHE SEQRES 17 B 232 SER CYS SER VAL MET HIS GLU ALA LEU HIS ASN HIS TYR SEQRES 18 B 232 THR GLN LYS SER LEU SER LEU SER PRO GLY LYS SEQRES 1 H 231 LEU LEU LEU VAL ALA ALA PRO ARG TRP LEU SER GLN LEU SEQRES 2 H 231 GLN LEU GLN GLU SER GLY PRO GLY LEU VAL LYS PRO SER SEQRES 3 H 231 GLU THR LEU SER LEU THR CYS THR VAL SER GLY GLY SER SEQRES 4 H 231 ILE SER ARG GLY SER HIS TYR TRP GLY TRP ILE ARG GLN SEQRES 5 H 231 PRO PRO GLY LYS GLY LEU GLU TRP ILE GLY SER ILE TYR SEQRES 6 H 231 TYR SER GLY ASN THR TYR PHE ASN PRO SER LEU LYS SER SEQRES 7 H 231 ARG VAL THR ILE SER VAL ASP THR SER LYS ASN GLN PHE SEQRES 8 H 231 SER LEU LYS LEU SER SER VAL THR ALA ALA ASP THR ALA SEQRES 9 H 231 VAL TYR TYR CYS ALA ARG LEU GLY PRO ASP ASP TYR THR SEQRES 10 H 231 LEU ASP GLY MET ASP VAL TRP GLY GLN GLY THR THR VAL SEQRES 11 H 231 THR VAL SER SER GLY SER ALA SER ALA PRO THR LEU PHE SEQRES 12 H 231 PRO LEU VAL SER CYS ASP THR SER SER VAL ALA VAL GLY SEQRES 13 H 231 CYS LEU ALA GLN ASP PHE LEU PRO ASP SER ILE THR PHE SEQRES 14 H 231 SER TRP LYS TYR LYS ASN ASN SER ASP ILE SER SER THR SEQRES 15 H 231 ARG GLY PHE PRO SER VAL LEU ARG GLY GLY LYS TYR ALA SEQRES 16 H 231 ALA THR SER GLN VAL LEU LEU PRO SER LYS ASP VAL MET SEQRES 17 H 231 GLN GLY THR ASP GLU HIS VAL VAL CYS LYS VAL GLN HIS SEQRES 18 H 231 PRO ASN GLY ASN LYS GLU LYS ASN VAL PRO SEQRES 1 I 231 LEU LEU LEU VAL ALA ALA PRO ARG TRP LEU SER GLN LEU SEQRES 2 I 231 GLN LEU GLN GLU SER GLY PRO GLY LEU VAL LYS PRO SER SEQRES 3 I 231 GLU THR LEU SER LEU THR CYS THR VAL SER GLY GLY SER SEQRES 4 I 231 ILE SER ARG GLY SER HIS TYR TRP GLY TRP ILE ARG GLN SEQRES 5 I 231 PRO PRO GLY LYS GLY LEU GLU TRP ILE GLY SER ILE TYR SEQRES 6 I 231 TYR SER GLY ASN THR TYR PHE ASN PRO SER LEU LYS SER SEQRES 7 I 231 ARG VAL THR ILE SER VAL ASP THR SER LYS ASN GLN PHE SEQRES 8 I 231 SER LEU LYS LEU SER SER VAL THR ALA ALA ASP THR ALA SEQRES 9 I 231 VAL TYR TYR CYS ALA ARG LEU GLY PRO ASP ASP TYR THR SEQRES 10 I 231 LEU ASP GLY MET ASP VAL TRP GLY GLN GLY THR THR VAL SEQRES 11 I 231 THR VAL SER SER GLY SER ALA SER ALA PRO THR LEU PHE SEQRES 12 I 231 PRO LEU VAL SER CYS ASP THR SER SER VAL ALA VAL GLY SEQRES 13 I 231 CYS LEU ALA GLN ASP PHE LEU PRO ASP SER ILE THR PHE SEQRES 14 I 231 SER TRP LYS TYR LYS ASN ASN SER ASP ILE SER SER THR SEQRES 15 I 231 ARG GLY PHE PRO SER VAL LEU ARG GLY GLY LYS TYR ALA SEQRES 16 I 231 ALA THR SER GLN VAL LEU LEU PRO SER LYS ASP VAL MET SEQRES 17 I 231 GLN GLY THR ASP GLU HIS VAL VAL CYS LYS VAL GLN HIS SEQRES 18 I 231 PRO ASN GLY ASN LYS GLU LYS ASN VAL PRO SEQRES 1 L 234 MET ALA GLY PHE PRO LEU LEU LEU THR LEU LEU THR HIS SEQRES 2 L 234 CYS ALA GLY SER TRP ALA GLN SER VAL LEU THR GLN PRO SEQRES 3 L 234 PRO SER ALA SER GLY THR PRO GLY GLN ARG VAL THR ILE SEQRES 4 L 234 SER CYS SER GLY SER SER SER ASN ILE GLY SER ASN TYR SEQRES 5 L 234 VAL TYR TRP TYR GLN GLN LEU PRO GLY THR ALA PRO LYS SEQRES 6 L 234 LEU LEU ILE TYR ARG ASN ASN GLN ARG PRO SER GLY VAL SEQRES 7 L 234 PRO ASP ARG PHE SER GLY SER LYS SER GLY THR SER ALA SEQRES 8 L 234 SER LEU ALA ILE SER GLY LEU ARG SER GLU ASP GLU ALA SEQRES 9 L 234 ASP TYR TYR CYS ALA THR TRP ASP ASP SER LEU SER ALA SEQRES 10 L 234 VAL ILE PHE GLY GLY GLY THR LYS LEU THR VAL LEU GLY SEQRES 11 L 234 GLN PRO LYS ALA ALA PRO SER VAL THR LEU PHE PRO PRO SEQRES 12 L 234 SER SER GLU GLU LEU GLN ALA ASN LYS ALA THR LEU VAL SEQRES 13 L 234 CYS LEU ILE SER ASP PHE PHE PRO GLY ALA VAL THR VAL SEQRES 14 L 234 ALA TRP LYS ALA ASP GLY ALA PRO VAL LYS ALA GLY VAL SEQRES 15 L 234 GLU THR THR LYS PRO SER LYS GLN SER ASN ASN LYS TYR SEQRES 16 L 234 ALA ALA SER SER TYR LEU SER LEU THR PRO GLU GLN TRP SEQRES 17 L 234 LYS SER HIS ARG SER TYR SER CYS GLN VAL THR HIS GLU SEQRES 18 L 234 GLY SER THR VAL GLU LYS THR VAL ALA PRO THR GLU CYS SEQRES 1 M 234 MET ALA GLY PHE PRO LEU LEU LEU THR LEU LEU THR HIS SEQRES 2 M 234 CYS ALA GLY SER TRP ALA GLN SER VAL LEU THR GLN PRO SEQRES 3 M 234 PRO SER ALA SER GLY THR PRO GLY GLN ARG VAL THR ILE SEQRES 4 M 234 SER CYS SER GLY SER SER SER ASN ILE GLY SER ASN TYR SEQRES 5 M 234 VAL TYR TRP TYR GLN GLN LEU PRO GLY THR ALA PRO LYS SEQRES 6 M 234 LEU LEU ILE TYR ARG ASN ASN GLN ARG PRO SER GLY VAL SEQRES 7 M 234 PRO ASP ARG PHE SER GLY SER LYS SER GLY THR SER ALA SEQRES 8 M 234 SER LEU ALA ILE SER GLY LEU ARG SER GLU ASP GLU ALA SEQRES 9 M 234 ASP TYR TYR CYS ALA THR TRP ASP ASP SER LEU SER ALA SEQRES 10 M 234 VAL ILE PHE GLY GLY GLY THR LYS LEU THR VAL LEU GLY SEQRES 11 M 234 GLN PRO LYS ALA ALA PRO SER VAL THR LEU PHE PRO PRO SEQRES 12 M 234 SER SER GLU GLU LEU GLN ALA ASN LYS ALA THR LEU VAL SEQRES 13 M 234 CYS LEU ILE SER ASP PHE PHE PRO GLY ALA VAL THR VAL SEQRES 14 M 234 ALA TRP LYS ALA ASP GLY ALA PRO VAL LYS ALA GLY VAL SEQRES 15 M 234 GLU THR THR LYS PRO SER LYS GLN SER ASN ASN LYS TYR SEQRES 16 M 234 ALA ALA SER SER TYR LEU SER LEU THR PRO GLU GLN TRP SEQRES 17 M 234 LYS SER HIS ARG SER TYR SER CYS GLN VAL THR HIS GLU SEQRES 18 M 234 GLY SER THR VAL GLU LYS THR VAL ALA PRO THR GLU CYS MODRES 2J6E ASN A 297 ASN GLYCOSYLATION SITE MODRES 2J6E ASN B 297 ASN GLYCOSYLATION SITE HET NAG C 1 14 HET NAG C 2 14 HET BMA C 3 11 HET MAN C 4 11 HET NAG C 5 14 HET GAL C 6 11 HET BMA C 7 11 HET NAG C 8 14 HET FUL C 9 10 HET NAG D 1 14 HET NAG D 2 14 HET BMA D 3 11 HET MAN D 4 11 HET NAG D 5 14 HET GAL D 6 11 HET BMA D 7 11 HET NAG D 8 14 HET FUL D 9 10 HET CD A 501 1 HET ZN A 502 1 HET CAC A 503 5 HET MPD A 504 8 HET MPD A 505 8 HET MPD A 506 8 HET ACT A 507 4 HET ACT A 508 4 HET ZN B 501 1 HET MPD B 502 8 HET MPD B 503 8 HET ACT B 504 4 HET ACT H 301 4 HET MPD M 301 8 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM BMA BETA-D-MANNOPYRANOSE HETNAM MAN ALPHA-D-MANNOPYRANOSE HETNAM GAL BETA-D-GALACTOPYRANOSE HETNAM FUL BETA-L-FUCOPYRANOSE HETNAM CD CADMIUM ION HETNAM ZN ZINC ION HETNAM CAC CACODYLATE ION HETNAM MPD (4S)-2-METHYL-2,4-PENTANEDIOL HETNAM ACT ACETATE ION HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE HETSYN BMA BETA-D-MANNOSE; D-MANNOSE; MANNOSE HETSYN MAN ALPHA-D-MANNOSE; D-MANNOSE; MANNOSE HETSYN GAL BETA-D-GALACTOSE; D-GALACTOSE; GALACTOSE HETSYN FUL BETA-L-FUCOSE; 6-DEOXY-BETA-L-GALACTOPYRANOSE; L- HETSYN 2 FUL FUCOSE; FUCOSE; 6-DEOXY-BETA-L-GALACTOSE HETSYN CAC DIMETHYLARSINATE FORMUL 7 NAG 8(C8 H15 N O6) FORMUL 7 BMA 4(C6 H12 O6) FORMUL 7 MAN 2(C6 H12 O6) FORMUL 7 GAL 2(C6 H12 O6) FORMUL 7 FUL 2(C6 H12 O5) FORMUL 9 CD CD 2+ FORMUL 10 ZN 2(ZN 2+) FORMUL 11 CAC C2 H6 AS O2 1- FORMUL 12 MPD 6(C6 H14 O2) FORMUL 15 ACT 4(C2 H3 O2 1-) FORMUL 23 HOH *84(H2 O) HELIX 1 1 LYS A 246 MET A 252 1 7 HELIX 2 2 LEU A 309 ASN A 315 1 7 HELIX 3 3 SER A 354 LEU A 358 5 5 HELIX 4 4 LYS A 414 GLY A 420 1 7 HELIX 5 5 LEU A 432 ASN A 434 5 3 HELIX 6 6 LYS B 246 MET B 252 1 7 HELIX 7 7 LEU B 309 ASN B 315 1 7 HELIX 8 8 SER B 354 LYS B 360 5 7 HELIX 9 9 LYS B 414 GLN B 419 1 6 HELIX 10 10 LEU B 432 TYR B 436 5 5 HELIX 11 11 SER H 28 GLY H 32 5 5 HELIX 12 12 LEU H 63 SER H 65 5 3 HELIX 13 13 SER I 28 GLY I 32 5 5 HELIX 14 14 PRO I 61 LYS I 64 5 4 HELIX 15 15 THR I 73 LYS I 75 5 3 HELIX 16 16 THR I 83 THR I 87 5 5 HELIX 17 17 SER L 121 GLN L 126 1 6 HELIX 18 18 THR L 181 TRP L 185 5 5 HELIX 19 19 GLY A 236 SER M 30 5 31 HELIX 20 20 THR M 181 LYS M 186 1 6 SHEET 1 AA 4 SER A 239 PHE A 243 0 SHEET 2 AA 4 GLU A 258 VAL A 266 -1 O THR A 260 N PHE A 243 SHEET 3 AA 4 TYR A 300 THR A 307 -1 O TYR A 300 N VAL A 266 SHEET 4 AA 4 LYS A 288 GLU A 294 -1 O LYS A 288 N VAL A 305 SHEET 1 AB 4 VAL A 282 VAL A 284 0 SHEET 2 AB 4 VAL A 273 VAL A 279 -1 O TRP A 277 N VAL A 284 SHEET 3 AB 4 TYR A 319 ASN A 325 -1 O LYS A 320 N TYR A 278 SHEET 4 AB 4 ILE A 332 ILE A 336 -1 O ILE A 332 N VAL A 323 SHEET 1 AC 4 GLN A 347 LEU A 351 0 SHEET 2 AC 4 GLN A 362 PHE A 372 -1 O THR A 366 N LEU A 351 SHEET 3 AC 4 PHE A 404 ASP A 413 -1 O PHE A 404 N PHE A 372 SHEET 4 AC 4 TYR A 391 THR A 393 -1 O LYS A 392 N LYS A 409 SHEET 1 AD 4 GLN A 347 LEU A 351 0 SHEET 2 AD 4 GLN A 362 PHE A 372 -1 O THR A 366 N LEU A 351 SHEET 3 AD 4 PHE A 404 ASP A 413 -1 O PHE A 404 N PHE A 372 SHEET 4 AD 4 VAL A 397 LEU A 398 -1 O VAL A 397 N PHE A 405 SHEET 1 AE 3 ALA A 378 SER A 383 0 SHEET 2 AE 3 VAL A 422 MET A 428 -1 O SER A 424 N GLU A 382 SHEET 3 AE 3 TYR A 436 SER A 442 -1 O THR A 437 N VAL A 427 SHEET 1 BA 4 SER B 239 PHE B 243 0 SHEET 2 BA 4 GLU B 258 VAL B 264 -1 O THR B 260 N PHE B 243 SHEET 3 BA 4 TYR B 300 THR B 307 -1 O VAL B 302 N VAL B 263 SHEET 4 BA 4 GLU B 293 GLU B 294 -1 O GLU B 293 N ARG B 301 SHEET 1 BB 3 PHE B 275 VAL B 279 0 SHEET 2 BB 3 TYR B 319 VAL B 323 -1 O LYS B 320 N TYR B 278 SHEET 3 BB 3 GLU B 333 ILE B 336 -1 O LYS B 334 N CYS B 321 SHEET 1 BC 4 GLN B 347 LEU B 351 0 SHEET 2 BC 4 GLN B 362 PHE B 372 -1 O THR B 366 N LEU B 351 SHEET 3 BC 4 PHE B 404 ASP B 413 -1 O PHE B 404 N PHE B 372 SHEET 4 BC 4 TYR B 391 THR B 393 -1 O LYS B 392 N LYS B 409 SHEET 1 BD 4 GLN B 347 LEU B 351 0 SHEET 2 BD 4 GLN B 362 PHE B 372 -1 O THR B 366 N LEU B 351 SHEET 3 BD 4 PHE B 404 ASP B 413 -1 O PHE B 404 N PHE B 372 SHEET 4 BD 4 VAL B 397 LEU B 398 -1 O VAL B 397 N PHE B 405 SHEET 1 BE 3 ALA B 378 GLU B 382 0 SHEET 2 BE 3 PHE B 423 MET B 428 -1 O SER B 424 N GLU B 382 SHEET 3 BE 3 THR B 437 LEU B 441 -1 O THR B 437 N VAL B 427 SHEET 1 HA 4 GLN H 3 SER H 7 0 SHEET 2 HA 4 THR H 17 SER H 25 -1 O THR H 21 N SER H 7 SHEET 3 HA 4 GLN H 77 SER H 82A-1 O PHE H 78 N CYS H 22 SHEET 4 HA 4 VAL H 67 ASP H 72 -1 O THR H 68 N LYS H 81 SHEET 1 HB 5 THR H 57 PHE H 59 0 SHEET 2 HB 5 GLU H 46 ILE H 51 -1 O SER H 50 N TYR H 58 SHEET 3 HB 5 TRP H 35A GLN H 39 -1 O TRP H 35A N ILE H 51 SHEET 4 HB 5 ALA H 88 LEU H 95 -1 O VAL H 89 N GLN H 39 SHEET 5 HB 5 THR H 108 VAL H 109 -1 O VAL H 109 N ALA H 88 SHEET 1 HC 5 THR H 57 PHE H 59 0 SHEET 2 HC 5 GLU H 46 ILE H 51 -1 O SER H 50 N TYR H 58 SHEET 3 HC 5 TRP H 35A GLN H 39 -1 O TRP H 35A N ILE H 51 SHEET 4 HC 5 ALA H 88 LEU H 95 -1 O VAL H 89 N GLN H 39 SHEET 5 HC 5 MET H 100E TRP H 103 -1 N ASP H 101 O ARG H 94 SHEET 1 HD 3 THR H 120 PRO H 123 0 SHEET 2 HD 3 VAL H 136 GLN H 143 -1 O LEU H 141 N PHE H 122 SHEET 3 HD 3 GLN H 182 LEU H 185 -1 O VAL H 183 N VAL H 138 SHEET 1 HE 3 TRP H 154 LYS H 155 0 SHEET 2 HE 3 VAL H 198 LYS H 201 -1 O VAL H 199 N LYS H 155 SHEET 3 HE 3 GLU H 210 VAL H 213 -1 O LYS H 211 N CYS H 200 SHEET 1 HF 2 VAL H 171 LEU H 172 0 SHEET 2 HF 2 TYR H 177 ALA H 178 -1 O ALA H 178 N VAL H 171 SHEET 1 IA 4 GLN I 3 SER I 7 0 SHEET 2 IA 4 LEU I 18 SER I 25 -1 O THR I 21 N SER I 7 SHEET 3 IA 4 GLN I 77 LEU I 82 -1 O PHE I 78 N CYS I 22 SHEET 4 IA 4 ILE I 69 ASP I 72 -1 O SER I 70 N SER I 79 SHEET 1 IB 9 LEU I 11 VAL I 12 0 SHEET 2 IB 9 THR I 107 VAL I 111 1 O THR I 110 N VAL I 12 SHEET 3 IB 9 ALA I 88 LEU I 95 -1 O ALA I 88 N VAL I 109 SHEET 4 IB 9 THR I 57 PHE I 59 0 SHEET 5 IB 9 GLU I 46 ILE I 51 -1 O SER I 50 N TYR I 58 SHEET 6 IB 9 TRP I 35A GLN I 39 -1 O TRP I 35A N ILE I 51 SHEET 7 IB 9 ALA I 88 LEU I 95 -1 O VAL I 89 N GLN I 39 SHEET 8 IB 9 ASP I 101 TRP I 103 -1 O VAL I 102 N ARG I 94 SHEET 9 IB 9 ALA I 88 LEU I 95 -1 O ARG I 94 N VAL I 102 SHEET 1 IC 7 THR I 120 LEU I 124 0 SHEET 2 IC 7 VAL I 136 GLN I 143 -1 O GLY I 139 N LEU I 124 SHEET 3 IC 7 LYS I 176 LEU I 185 -1 O ALA I 179 N ALA I 142 SHEET 4 IC 7 ARG I 166 GLY I 167 -1 O ARG I 166 N GLN I 182 SHEET 5 IC 7 LYS I 176 LEU I 185 -1 O GLN I 182 N ARG I 166 SHEET 6 IC 7 VAL I 171 ARG I 173 -1 O VAL I 171 N ALA I 178 SHEET 7 IC 7 LYS I 176 LEU I 185 -1 O LYS I 176 N ARG I 173 SHEET 1 ID 3 PHE I 152 LYS I 155 0 SHEET 2 ID 3 VAL I 198 VAL I 202 -1 O VAL I 199 N LYS I 155 SHEET 3 ID 3 LYS I 209 VAL I 213 -1 O LYS I 209 N VAL I 202 SHEET 1 LA 3 ARG L 17 SER L 23 0 SHEET 2 LA 3 SER L 70 SER L 76 -1 O ALA L 71 N CYS L 22 SHEET 3 LA 3 PHE L 62 SER L 67 -1 O SER L 63 N ALA L 74 SHEET 1 LB 4 LYS L 45 ILE L 48 0 SHEET 2 LB 4 TYR L 34 GLN L 38 -1 O TRP L 35 N LEU L 47 SHEET 3 LB 4 ASP L 85 ASP L 92 -1 O ASP L 85 N GLN L 38 SHEET 4 LB 4 ALA L 95B PHE L 98 -1 O ALA L 95B N ASP L 92 SHEET 1 LC 4 LEU L 117 PHE L 118 0 SHEET 2 LC 4 LEU L 132 CYS L 134 -1 N VAL L 133 O PHE L 118 SHEET 3 LC 4 SER L 176 LEU L 178 -1 O SER L 176 N CYS L 134 SHEET 4 LC 4 VAL L 159 THR L 161 -1 O GLU L 160 N TYR L 177 SHEET 1 LD 4 ALA L 153 PRO L 154 0 SHEET 2 LD 4 THR L 145 ALA L 150 -1 N ALA L 150 O ALA L 153 SHEET 3 LD 4 TYR L 191 THR L 196 -1 O SER L 192 N LYS L 149 SHEET 4 LD 4 LYS L 204 VAL L 206 -1 O LYS L 204 N CYS L 193 SHEET 1 MA 3 VAL M 18 SER M 23 0 SHEET 2 MA 3 SER M 70 ILE M 75 -1 O ALA M 71 N CYS M 22 SHEET 3 MA 3 PHE M 62 SER M 65 -1 O SER M 63 N ALA M 74 SHEET 1 MB 7 LEU M 46 ILE M 48 0 SHEET 2 MB 7 TYR M 34 GLN M 38 -1 O TRP M 35 N LEU M 47 SHEET 3 MB 7 ALA M 84 ASP M 92 -1 O ASP M 85 N GLN M 38 SHEET 4 MB 7 ALA M 95B PHE M 98 -1 O ALA M 95B N ASP M 92 SHEET 5 MB 7 ALA M 84 ASP M 92 -1 O THR M 90 N ILE M 97 SHEET 6 MB 7 THR M 102 LEU M 104 -1 O THR M 102 N TYR M 86 SHEET 7 MB 7 ALA M 84 ASP M 92 -1 O ALA M 84 N LEU M 104 SHEET 1 MC 3 LEU M 117 PHE M 118 0 SHEET 2 MC 3 LEU M 132 CYS M 134 -1 O VAL M 133 N PHE M 118 SHEET 3 MC 3 SER M 176 LEU M 178 -1 O SER M 176 N CYS M 134 SHEET 1 MD 2 ASP M 138 PHE M 139 0 SHEET 2 MD 2 TYR M 172 ALA M 173 -1 O TYR M 172 N PHE M 139 SHEET 1 ME 4 ALA M 153 PRO M 154 0 SHEET 2 ME 4 VAL M 146 ALA M 150 -1 N ALA M 150 O ALA M 153 SHEET 3 ME 4 TYR M 191 VAL M 195 -1 O SER M 192 N LYS M 149 SHEET 4 ME 4 GLU M 203 VAL M 206 -1 O LYS M 204 N CYS M 193 SSBOND 1 CYS A 261 CYS A 321 1555 1555 2.04 SSBOND 2 CYS A 367 CYS A 425 1555 1555 2.04 SSBOND 3 CYS B 261 CYS B 321 1555 1555 2.03 SSBOND 4 CYS B 367 CYS B 425 1555 1555 2.03 SSBOND 5 CYS H 22 CYS H 92 1555 1555 2.04 SSBOND 6 CYS H 140 CYS H 200 1555 1555 2.03 SSBOND 7 CYS I 22 CYS I 92 1555 1555 2.05 SSBOND 8 CYS I 140 CYS I 200 1555 1555 2.03 SSBOND 9 CYS L 22 CYS L 88 1555 1555 2.03 SSBOND 10 CYS L 134 CYS L 193 1555 1555 2.04 SSBOND 11 CYS M 22 CYS M 88 1555 1555 2.04 SSBOND 12 CYS M 134 CYS M 193 1555 1555 2.03 LINK ND2 ASN A 297 C1 NAG C 1 1555 1555 1.45 LINK ND2 ASN B 297 C1 NAG D 1 1555 1555 1.46 LINK O4 NAG C 1 C1 NAG C 2 1555 1555 1.38 LINK O6 NAG C 1 C1 FUL C 9 1555 1555 1.39 LINK O4 NAG C 2 C1 BMA C 3 1555 1555 1.39 LINK O6 BMA C 3 C1 MAN C 4 1555 1555 1.39 LINK O3 BMA C 3 C1 BMA C 7 1555 1555 1.40 LINK O2 MAN C 4 C1 NAG C 5 1555 1555 1.39 LINK O4 NAG C 5 C1 GAL C 6 1555 1555 1.39 LINK O2 BMA C 7 C1 NAG C 8 1555 1555 1.39 LINK O4 NAG D 1 C1 NAG D 2 1555 1555 1.39 LINK O6 NAG D 1 C1 FUL D 9 1555 1555 1.41 LINK O4 NAG D 2 C1 BMA D 3 1555 1555 1.39 LINK O6 BMA D 3 C1 MAN D 4 1555 1555 1.40 LINK O3 BMA D 3 C1 BMA D 7 1555 1555 1.40 LINK O2 MAN D 4 C1 NAG D 5 1555 1555 1.39 LINK O4 NAG D 5 C1 GAL D 6 1555 1555 1.39 LINK O2 BMA D 7 C1 NAG D 8 1555 1555 1.40 LINK NE2 HIS A 268 CD CD A 501 4546 1555 2.23 LINK OE1 GLU A 272 ZN ZN A 502 4546 1555 2.07 LINK OE2 GLU A 272 ZN ZN A 502 4546 1555 1.93 LINK OE1 GLU A 294 CD CD A 501 4546 1555 2.82 LINK OE2 GLU A 294 CD CD A 501 4546 1555 2.01 LINK NE2 HIS A 310 CD CD A 501 1555 1555 2.04 LINK OE1 GLU A 345 ZN ZN A 502 1555 1555 2.58 LINK OE2 GLU A 345 ZN ZN A 502 1555 1555 1.94 LINK NE2 HIS A 433 ZN ZN A 502 1555 1555 2.07 LINK NE2 HIS A 435 CD CD A 501 1555 1555 2.29 LINK ZN ZN A 502 O1 CAC A 503 1555 1555 2.68 LINK ZN ZN B 501 NE2 HIS M 188 1555 4545 2.10 CISPEP 1 TYR A 373 PRO A 374 0 0.15 CISPEP 2 TYR B 373 PRO B 374 0 -0.03 CISPEP 3 PHE L 140 PRO L 141 0 0.16 CISPEP 4 PHE M 140 PRO M 141 0 -0.30 CRYST1 241.980 75.610 102.400 90.00 91.13 90.00 C 1 2 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.004133 0.000000 0.000082 0.00000 SCALE2 0.000000 0.013226 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009768 0.00000